demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 all comersCOVID-19 mild to moderate
COVID 19 hospitalizedCOVID 19 all comersCOVID-19 mild to moderate
hydroxychloroquine plus macrolides Rosenberg Carlucci Sbidian ... Lagier Arshad ... Davido Duke university HCQ-AZI Magagnoli ...
azithromycin plus hydroxychloroquine ProPAC-COVID Coalition Covid-19 Brazil I ...

0 studies excluded by filtering options 2